1. Home
  2. TRN vs TARS Comparison

TRN vs TARS Comparison

Compare TRN & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trinity Industries Inc.

TRN

Trinity Industries Inc.

HOLD

Current Price

$33.53

Market Cap

2.8B

Sector

Industrials

ML Signal

HOLD

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$63.19

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRN
TARS
Founded
1933
2016
Country
United States
United States
Employees
N/A
370
Industry
Railroads
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.7B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
TRN
TARS
Price
$33.53
$63.19
Analyst Decision
Hold
Buy
Analyst Count
1
6
Target Price
$34.00
$89.00
AVG Volume (30 Days)
545.4K
649.2K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
4.03%
N/A
EPS Growth
85.98
48.21
EPS
0.30
N/A
Revenue
$2,156,900,000.00
$451,360,000.00
Revenue This Year
$1.91
$56.43
Revenue Next Year
$15.61
$30.19
P/E Ratio
$110.58
N/A
Revenue Growth
N/A
146.71
52 Week Low
$22.38
$38.51
52 Week High
$37.36
$85.25

Technical Indicators

Market Signals
Indicator
TRN
TARS
Relative Strength Index (RSI) 47.02 48.25
Support Level $27.09 $60.38
Resistance Level $35.33 $67.24
Average True Range (ATR) 1.32 3.65
MACD -0.29 0.23
Stochastic Oscillator 25.15 62.71

Price Performance

Historical Comparison
TRN
TARS

About TRN Trinity Industries Inc.

Trinity Industries Inc sells and leases railroad products and railcar maintenance services in North America. The company operates under the name TrinityRail in two main segments: railcar leasing and management services, which owns railcars and provides fleet management and administration services; rail products, which builds, sells, and modifies freight and tank railcars and their components; and all other, which sells highway products such as guardrail and other highway barriers. Customers include railroads, leasing companies, and shipping companies in agriculture, construction, consumer products, energy, and chemicals.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Share on Social Networks: